VAXCYTE INC. - COMMON STOCK
29.00
07-May-25 16:45:00
15 minutes delayed
Stocks
-0.24
-0.82%
Today's range
28.09 - 30.04
ISIN
N/A
Source
NASDAQ
-
Vaxcyte to Present at Upcoming Investor Conferences
11 Nov 2021 16:05:01 By Nasdaq GlobeNewswire
-
Vaxcyte Reports Third Quarter 2021 Financial Results and Provides Business Update
10 Nov 2021 16:10:00 By Nasdaq GlobeNewswire
-
Vaxcyte Appoints Carlos Paya and Michael Kamarck to Its Board of Directors
28 Oct 2021 08:30:00 By Nasdaq GlobeNewswire
-
Vaxcyte to Present at Guggenheim 2nd Annual Vaccine and Infectious Disease Conference
28 Sep 2021 16:05:00 By Nasdaq GlobeNewswire
-
Vaxcyte to Present at 2021 Cantor Virtual Global Healthcare Conference
21 Sep 2021 16:01:00 By Nasdaq GlobeNewswire
-
Vaxcyte Appoints Annie Drapeau and Teri Loxam to Its Board of Directors
20 Sep 2021 16:30:00 By Nasdaq GlobeNewswire
-
Vaxcyte Reports Second Quarter 2021 Financial Results and Provides Business Update
11 Aug 2021 16:07:45 By Nasdaq GlobeNewswire
-
05 Aug 2021 08:30:01 By Nasdaq GlobeNewswire
-
Vaxcyte to Present at the Jefferies Virtual Healthcare Conference
27 May 2021 16:05:00 By Nasdaq GlobeNewswire
-
Vaxcyte Reports First Quarter 2021 Financial Results and Provides Business Update
11 May 2021 16:10:00 By Nasdaq GlobeNewswire
-
10 May 2021 08:30:00 By Nasdaq GlobeNewswire
-
Vaxcyte to Present at BofA Securities 2021 Health Care Conference
06 May 2021 16:05:02 By Nasdaq GlobeNewswire
-
Vaxcyte to Present at 20th Annual Needham Virtual Healthcare Conference
05 Apr 2021 16:30:00 By Nasdaq GlobeNewswire
-
Vaxcyte Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
29 Mar 2021 16:10:00 By Nasdaq GlobeNewswire
-
Vaxcyte to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021
22 Mar 2021 16:05:00 By Nasdaq GlobeNewswire
-
06 Jan 2021 08:15:00 By Nasdaq GlobeNewswire